Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 296 entries
View as:

A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04707248 Org: User:
Start: 12/22/20 End: 11/30/25 Due: 11/30/26

A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT01588678 Org: User:
Start: 04/30/12 End: 06/30/14 Due: 06/30/15

A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)

Phase: N/A Priority: Normal
NCT ID: NCT06210776 Org: User:
Start: 01/15/24 End: 03/01/28 Due: 03/01/29

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT00185042 Org: User:
Start: 11/30/02 End: 07/31/05 Due: 07/31/06

A Study of DS-2248 in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01288430 Org: User:
Start: 03/29/11 End: 02/13/14 Due: 02/13/15

A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT01390337 Org: User:
Start: 10/31/11 End: 02/28/15 Due: 02/28/16

Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China

Phase: N/A Priority: Normal
NCT ID: NCT06546202 Org: User:
Start: 08/16/24 End: 08/30/25 Due: 08/30/26

Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04145622 Org: User:
Start: 11/03/19 End: 03/01/27 Due: 03/01/28

A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05979831 Org: User:
Start: 09/28/23 End: 01/06/25 Due: 01/06/26

A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT05400369 Org: User:
Start: 08/10/22 End: 09/25/24 Due: 09/25/25

Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)

Phase: N/A Priority: Normal
NCT ID: NCT04703192 Org: User:
Start: 06/03/21 End: 09/08/25 Due: 09/08/26

Study to Assess the Effect of a CYP3A Weak Inducer Rufinamide on Quizartinib Pharmacokinetics in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06740825 Org: User:
Start: 10/29/24 End: 12/09/24 Due: 12/09/25

Effect of Probenecid on Pexidartinib Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT03138759 Org: User:
Start: 02/27/17 End: 03/30/17 Due: 03/30/18

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05875168 Org: User:
Start: 08/18/23 End: 07/11/27 Due: 07/11/28

DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00077077 Org: User:
Start: 02/29/04 End: 01/31/06 Due: 01/31/07

Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02299661 Org: User:
Start: 11/30/14 End: 05/31/15 Due: 05/31/16

Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00484419 Org: User:
Start: 05/31/07 End: 04/30/08 Due: 04/30/09

Prasugrel/Clopidogrel Maintenance Dose Washout Study

Phase: N/A Priority: Normal
NCT ID: NCT01014624 Org: User:
Start: 02/28/10 End: 06/30/10 Due: 06/30/11

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Phase: N/A Priority: Normal
NCT ID: NCT03395639 Org: User:
Start: 05/15/18 End: 12/03/21 Due: 12/03/22

Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00023972 Org: User:
Start: 07/31/01 End: 04/30/05 Due: 04/30/06

Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01245543 Org: User:
Start: 11/30/10 End: 06/30/13 Due: 06/30/14

Multiple Dose Study of DS-1971a

Phase: N/A Priority: Normal
NCT ID: NCT02190058 Org: User:
Start: 07/31/14 End: 11/30/14 Due: 11/30/15

Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00361153 Org: User:
Start: 05/31/06 End: 03/31/07 Due: 03/31/08

Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

Phase: N/A Priority: Normal
NCT ID: NCT04747496 Org: User:
Start: 02/26/21 End: 11/27/24 Due: 11/27/25

A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum

Phase: N/A Priority: Normal
NCT ID: NCT05569252 Org: User:
Start: 10/20/22 End: 11/21/23 Due: 11/21/24